1. Use of guideline-directed medical therapy (GDMT) in heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly ...
1. In this randomized controlled trial of patients with heart failure and mildly decreased or preserved ejection fraction, finerenone treatment ...
1. Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF patients. 2. ...
1. Semaglutide showed significant improvements in KCCQ-CSS score and reduction in body weight compared to placebo. 2. There were fewer ...
1. In this randomized controlled trial, semaglutide was more effective in reducing heart failure-related symptoms and physical limitations in patients ...
1. In this randomized controlled trial, in patients with heart failure with preserved ejection fraction semaglutide treatment led to reductions ...
1. Quality of life at one year was improved in patients with heart failure with preserved ejection fraction (HFpEF) who ...
1. In this decision analytical model study among 4.8 million adults with heart failure in the United States, optimal implementation ...
1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in patients with a mildly reduced ...
1. Dapagliflozin was shown to reduce the risk of disease progression and cardiovascular death in patients with a mildly reduced ...
